Proposed Data Collections Submitted for Public Comment and Recommendations

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[INFO-98-05]

Proposed Data Collections Submitted for Public Comment and

Recommendations

In compliance with the requirement of Section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995 for opportunity for public comment on

proposed data collection projects, the Centers for Disease Control and

Prevention (CDC) will publish periodic summaries of proposed projects.

To request more information on the proposed projects or to obtain a

copy of the data collection plans and instruments, call the CDC Reports

Clearance Officer on (404) 639-7090.

Comments are invited on: (a) Whether the proposed collection of

information is necessary for the proper performance of the functions of

the agency, including whether the information shall have practical

utility; (b) the accuracy of the agency's estimate of the burden of the

proposed collection of information; (c) ways to enhance the quality,

utility, and clarity of the information to be collected; and (d) ways

to minimize the burden of the collection of information on respondents,

including through the use of automated collection techniques for other

forms of information technology. Send comments to Wilma Johnson, CDC

Reports Clearance Officer, 1600 Clifton Road, MS-D24, Atlanta, GA

30333. Written comments should be received within 60 days of this

notice.

Proposed Projects

1. National Exposure Registry (0923-0006)--Extension--The

information collected is part of the Agency for Toxic Substances' on-

going National Exposure Registry (NER)--a database composed of a

listing of persons, along with health and demographic information, with

documented exposure to selected toxic substances subregistries). The

NER was

[[Page 63720]]

created in response to a Congressional Superfund mandate to create a

registry of persons with exposure to hazardous substances and a

registry of persons with illness or health problems as a result of

exposure to hazardous substances. The mandate was created because there

is little or no information available about the potential health

effects of low-level, long-term exposure to hazardous substances on a

general population--such as is found at waste sites. Unlike most

occupationally exposed populations, this environmentally-exposed

population has extremely vulnerable components such as pregnant women,

the elderly, those with compromised health, and children.

Since the adverse health effects are not known, neither is the

latency period for the potential health effects. Therefore, the NER is

a longitudinal project: a baseline and biennial follow-ups that will

continue until all parties involved agree the established criteria for

ending that chemical specific subregistry have been met. The

questionnaire is administered (usually in a personal interview) at

baseline; the same questionnaire is administered (using computer

assisted interviews) to each registrant longitudinally. The data is

compared to national norms at each collection and intrafile comparisons

are made over multiple collections. Other than their time to

participate, there is no cost to respondents. The period requested is

for 3 years.

----------------------------------------------------------------------------------------------------------------

No. of Avg. burden/ Total

Respondents No. of responses/ response burden (in

respondents respondent (in hrs.) hrs.)

----------------------------------------------------------------------------------------------------------------

Established Registrants..................................... 7,333 1 0.25 1,833

New Registrants............................................. 4,300 1 .5 2,150

---------------------------------------------------

Total................................................... ........... ........... ........... 3,983

----------------------------------------------------------------------------------------------------------------

Dated: November 25, 1997.

Wilma G. Johnson,

Acting Associate Director for Policy Planning And Evaluation, Centers

for Disease Control and Prevention (CDC).

[FR Doc. 97-31533 Filed 12-1-97; 8:45 am]

BILLING CODE 4163-18-P